Skip to main content
logo
BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
3.800
-0.040 (-1.04%)
At close: Dec 30, 2025

BioStem Technologies Revenue

BioStem Technologies had revenue of $10.47M in the quarter ending September 30, 2025, a decrease of -43.12%. This brings the company's revenue in the last twelve months to $292.21M, up 399.02% year-over-year. In the year 2024, BioStem Technologies had annual revenue of $301.83M with 1,708.93% growth.

Revenue (ttm)
292.21M
Revenue Growth
+399.02%
P/S Ratio
0.22
Revenue / Employee
8.85M
Employees
33
Market Cap
64.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024301.83M285.14M1,708.93%
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M4.03M1,284.88%
Dec 31, 2017313.45K-293.78K-48.38%
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Global Cord Blood196.10M
Elite Pharmaceuticals122.89M
Silence Therapeutics25.83M
OpGen9.00M
Northwest Biotherapeutics937.00K
Revenue Rankings

BioStem Technologies News

More News